Unknown

Dataset Information

0

Immune checkpoint blockade for glioma

ABSTRACT: Abstract This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness and safety of anti‐PD‐1 and anti‐PD‐L1 antibodies in the treatment of adults with diffuse glioma.

SUBMITTER: de Melo S 

PROVIDER: S-EPMC6464918 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Immune-checkpoint blockade and active immunotherapy for glioma.
| S-EPMC3875944 | biostudies-literature
Unknown Recent Advances in Glioma Therapy: Combining Vascular Normalization and Immune Checkpoint Blockade.
| S-EPMC8345045 | biostudies-literature
Unknown Lighting a Fire: Gasdermin-Mediated Pyroptosis Remodels the Glioma Microenvironment and Promotes Immune Checkpoint Blockade Response.
| S-EPMC9249059 | biostudies-literature
Unknown Immune checkpoint blockade in infectious diseases.
| S-EPMC5991909 | biostudies-literature
Unknown Immune Checkpoint Blockade for Breast Cancer.
| S-EPMC6061922 | biostudies-literature
Unknown Immune-Checkpoint Blockade Therapy in Lymphoma.
| S-EPMC7432396 | biostudies-literature
Unknown Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade.
| S-EPMC5061538 | biostudies-other
Unknown Fulminant Myocarditis with Combination Immune Checkpoint Blockade.
| S-EPMC5247797 | biostudies-literature
Unknown Activation of phagocytosis by immune checkpoint blockade.
| S-EPMC6941417 | biostudies-literature
Unknown Acquired Resistance to Immune Checkpoint Blockade Therapies.
| S-EPMC7280955 | biostudies-literature